Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hypertension, Portal 3Carcinoma, Hepatocellular 3Hemangioma, Capillary 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Liver Cirrhosis 1Hemangiosarcoma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

lenvatinib 1Vitamin B 6 1Ultrasonography 1Tomography, X-Ray Computed 1Tidal Volume 1Radiomics 1Propranolol 1Portasystemic Shunt, Transjugular Intrahepatic 1Population Groups 1Plasmapheresis 1Nadolol 1Mebendazole 1Liquid Biopsy 1Injections 1Glutathione 1Gastroscopy 1Ferrosoferric Oxide 1Everolimus 1Dextrins 1Colonoscopy 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Liver Cirrhosis × Propranolol × Clear all
NCT01298284 2011-06-15

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡